| | |
Page
|
| |||
招股説明書副刊 | | | | | | | |
關於本招股説明書副刊
|
| | | | S-ii | | |
關於前瞻性陳述的特別説明
|
| | | | S-iii | | |
招股説明書補充摘要
|
| | | | S-1 | | |
RISK FACTORS
|
| | | | S-14 | | |
USE OF PROCEEDS
|
| | | | S-21 | | |
DILUTION
|
| | | | S-22 | | |
DIVIDEND POLICY
|
| | | | S-23 | | |
CAPITALIZATION
|
| | | | S-24 | | |
預先出資認股權證説明
|
| | | | S-25 | | |
美國聯邦所得税對非美國持有者的重大後果
我們的普通股和預付資金認股權證 |
| | | | S-27 | | |
UNDERWRITING
|
| | | | S-32 | | |
LEGAL MATTERS
|
| | | | S-39 | | |
EXPERTS
|
| | | | S-39 | | |
您可以在哪裏找到更多信息
|
| | | | S-39 | | |
引用合併
|
| | | | S-39 | | |
| PROSPECTUS | | | | | | | |
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
您可以在哪裏找到更多信息
|
| | | | 2 | | |
|
引用合併
|
| | | | 3 | | |
|
THE COMPANY
|
| | | | 4 | | |
|
本招股説明書下的產品
|
| | | | 7 | | |
|
RISK FACTORS
|
| | | | 8 | | |
|
關於前瞻性陳述的特別説明
|
| | | | 9 | | |
|
USE OF PROCEEDS
|
| | | | 10 | | |
|
股本説明
|
| | | | 10 | | |
|
債務證券説明
|
| | | | 15 | | |
|
認股權證説明
|
| | | | 21 | | |
|
證券的合法所有權
|
| | | | 22 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 25 | | |
|
LEGAL MATTERS
|
| | | | 27 | | |
|
EXPERTS
|
| | | | 27 | | |
| | | | | | | | | | | | | | | | | | | | |
Six Months Ended June 30,
|
| |||||||||
| | |
Year Ended December 31,
|
| |
(Unaudited)
|
| ||||||||||||||||||||||||
(以千為單位,不包括每股和每股信息)
|
| |
2019
|
| |
2020
|
| |
2021
|
| |
2021
|
| |
2022
|
| |||||||||||||||
操作報表數據: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net revenue
|
| | | $ | 72,552 | | | | | $ | 71,078 | | | | | $ | 98,049 | | | | | $ | 48,157 | | | | | $ | 56,345 | | |
Cost of revenue
|
| | | | 17,933 | | | | | | 16,047 | | | | | | 24,646 | | | | | | 11,389 | | | | | | 12,798 | | |
Gross profit
|
| | | | 54,619 | | | | | | 55,031 | | | | | | 73,403 | | | | | | 36,768 | | | | | | 43,547 | | |
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Sales and marketing
|
| | | | 31,284 | | | | | | 31,854 | | | | | | 39,673 | | | | | | 19,825 | | | | | | 22,189 | | |
一般和行政
|
| | | | 26,664 | | | | | | 38,317 | | | | | | 46,061 | | | | | | 23,129 | | | | | | 27,713 | | |
Legal settlement expenses
|
| | | | — | | | | | | 6,342 | | | | | | 150 | | | | | | — | | | | | | — | | |
Research and development
|
| | | | 5,748 | | | | | | 5,273 | | | | | | 5,543 | | | | | | 2,633 | | | | | | 3,774 | | |
Total operating expenses
|
| | | | 63,696 | | | | | | 81,786 | | | | | | 91,427 | | | | | | 45,587 | | | | | | 53,676 | | |
Operating loss
|
| | | | (9,077) | | | | | | (26,755) | | | | | | (18,024) | | | | | | (8,819) | | | | | | (10,129) | | |
Other expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | 3,538 | | | | | | 3,412 | | | | | | 2,247 | | | | | | 1,309 | | | | | | 1,777 | | |
或有對價的公允價值調整
|
| | | | — | | | | | | 3,520 | | | | | | (1,800) | | | | | | 5,140 | | | | | | (2,440) | | |
Other expenses (income)
|
| | | | 70 | | | | | | (20) | | | | | | (1,083) | | | | | | (535) | | | | | | 723 | | |
Total other expenses
|
| | | | 3,608 | | | | | | 6,912 | | | | | | (636) | | | | | | 5,914 | | | | | | 60 | | |
Loss before income taxes
|
| | | | (12,685) | | | | | | (33,667) | | | | | | (17,388) | | | | | | (14,733) | | | | | | (10,189) | | |
所得税準備金(福利)
|
| | | | — | | | | | | (723) | | | | | | (1,128) | | | | | | (598) | | | | | | (756) | | |
持續運營淨虧損
|
| | | | (12,685) | | | | | | (32,944) | | | | | | (16,260) | | | | | | (14,135) | | | | | | (9,433) | | |
停產淨虧損
|
| | | | (1,046) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Net loss
|
| | | $ | (13,731) | | | | | $ | (32,944) | | | | | $ | (16,260) | | | | | $ | (14,135) | | | | | $ | (9,433) | | |
加權平均普通股 - 基本股和稀釋股
|
| | | | 14,624,194 | | | | | | 18,056,828 | | | | | | 19,268,255 | | | | | | 19,263,506 | | | | | | 19,693,216 | | |
持續運營每股 - 基本和稀釋淨虧損(1)
|
| | | $ | (0.87) | | | | | $ | (1.82) | | | | | $ | (0.84) | | | | | $ | (0.73) | | | | | $ | (0.48) | | |
每小時停產淨虧損
share – basic and diluted |
| | | | (0.07) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Net loss per share – basic and diluted
|
| | | $ | (0.94) | | | | | $ | (1.82) | | | | | $ | (0.84) | | | | | $ | (0.73) | | | | | $ | (0.48) | | |
| | |
As of June 30, 2022
|
| |||||||||
(in thousands)
|
| |
Actual
|
| |
As Adjusted(1)
|
| ||||||
Balance sheet data: | | | | | | | | | | | | | |
現金、受限現金和短期投資(2)
|
| | | $ | 52,518 | | | | | $ | | | |
Working capital(3)
|
| | | | 116,935 | | | | | | | | |
Total debt
|
| | | | 31,977 | | | | | | | | |
Total stockholders’ equity
|
| | | | 227,216 | | | | | | | | |
Total capitalization
|
| | | | 259,193 | | | | | | | | |
| | |
Three Months Ended
June 30, |
| |
Six Months Ended
June 30, |
| ||||||||||||||||||
| | |
(Unaudited)
(In Thousands) |
| |||||||||||||||||||||
| | |
2022
|
| |
2021
|
| |
2022
|
| |
2021
|
| ||||||||||||
Net loss
|
| | | $ | (333) | | | | | $ | (3,756) | | | | | $ | (9,433) | | | | | $ | (14,135) | | |
Interest expense, net
|
| | | | 1,212 | | | | | | 581 | | | | | | 1,777 | | | | | | 1,309 | | |
Other expenses (income)
|
| | | | 827 | | | | | | (375) | | | | | | 723 | | | | | | (535) | | |
所得税準備金(福利)
|
| | | | (439) | | | | | | (286) | | | | | | (756) | | | | | | (598) | | |
折舊及攤銷
|
| | | | 3,331 | | | | | | 2,608 | | | | | | 6,292 | | | | | | 5,147 | | |
Stock-based compensation
|
| | | | 1,770 | | | | | | 1,415 | | | | | | 3,296 | | | | | | 2,731 | | |
或有對價的公允價值調整
|
| | | | (5,010) | | | | | | 990 | | | | | | (2,440) | | | | | | 5,140 | | |
Acquisition-related costs
|
| | | | 505 | | | | | | — | | | | | | 709 | | | | | | — | | |
非經常性專業費用
|
| | | | — | | | | | | 58 | | | | | | — | | | | | | 658 | | |
應計法律和解費用
|
| | | | — | | | | | | — | | | | | | — | | | | | | 150 | | |
最低採購承諾成本
|
| | | | 240 | | | | | | — | | | | | | 341 | | | | | | — | | |
Adjusted EBITDA
|
| | | $ | 2,103 | | | | | $ | 1,235 | | | | | $ | 509 | | | | | $ | (133) | | |
|
每股公開發行價
|
| | | | | | | | | $ | | | |
|
截至2022年6月30日的每股有形賬面淨值
|
| | | $ | 4.00 | | | | | | | | |
|
可歸因於投資者購買此次發行股票的每股有形賬面淨值增加
|
| | | | | | | | | | | | |
|
截至2022年6月30日調整後的每股有形賬面淨值
|
| | | | | | | | | | | | |
|
在此次發行中向新投資者每股攤薄
|
| | | | | | | | | $ | | | |
| | |
As of June 30, 2022
|
| |||||||||
(以千為單位,不包括每股和每股信息)
|
| |
Actual
|
| |
As Adjusted
|
| ||||||
現金、受限現金和短期投資
|
| | | $ | 52,518 | | | | | $ | | | |
Total debt
|
| | | $ | 31,977 | | | | | $ | | | |
Stockholders’ equity: | | | | | | | | | | | | | |
普通股,面值0.00025美元;授權股份50,000,000股;實際發行的20,238,870股;經本次發行調整後的已發行和已發行的 股份
|
| | | | 5 | | | | | | | | |
新增實收資本
|
| | | | 418,354 | | | | | | | | |
Accumulated deficit
|
| | | | (187,459) | | | | | | | | |
累計其他綜合收益(虧損)
|
| | | | (3,684) | | | | | | | | |
股東權益總額
|
| | | | 227,216 | | | | | | | | |
Total capitalization
|
| | | $ | 259,193 | | | | | $ | | | |
Underwriters
|
| |
Number of
Shares |
| |
Number of
Pre-Funded Warrants |
| ||||||
派珀·桑德勒公司
|
| | | | | | | | | | | | |
Stifel,Nicolaus&Company,公司
|
| | | | | | | | | | | ||
Total
|
| | | | | | | | | | | | |
| | |
No Exercise
|
| |
Full Exercise
|
| ||||||
Per share of common stock
|
| | | $ | | | | | $ | | | ||
Per pre-funded warrant
|
| | | $ | | | | | $ | | | ||
Total
|
| | | $ | | | | | $ | | | |
|
ORTHOPEDIATRICS
CORP. |
| |
![]() |
|
| | |
Page
|
| |||
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
您可以在哪裏找到更多信息
|
| | | | 2 | | |
引用合併
|
| | | | 3 | | |
THE COMPANY
|
| | | | 4 | | |
本招股説明書下的產品
|
| | | | 7 | | |
RISK FACTORS
|
| | | | 8 | | |
關於前瞻性陳述的特別説明
|
| | | | 9 | | |
USE OF PROCEEDS
|
| | | | 10 | | |
股本説明
|
| | | | 10 | | |
債務證券説明
|
| | | | 15 | | |
認股權證説明
|
| | | | 21 | | |
證券的合法所有權
|
| | | | 22 | | |
PLAN OF DISTRIBUTION
|
| | | | 25 | | |
LEGAL MATTERS
|
| | | | 27 | | |
EXPERTS
|
| | | | 27 | | |